Rare diseases
Investigational molecules
Locations
360 conditions with trials, the busiest first
863 trials across Europe, recruiting first
Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaStudy on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis
AustriaStudy of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors
BelgiumStudy on the Safety and Effects of EryDex with Dexamethasone Sodium Phosphate for Patients with Ataxia Telangiectasia
DenmarkStudy on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid
BulgariaStudy on Dupilumab for Treating Nummular Eczema in Patients
GermanyStudy on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
CzechiaStudy on Preventing Arterial Calcification in Young Patients with Pseudoxanthoma Elasticum Using Etidronate
The NetherlandsStudy on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents
The NetherlandsStudy on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers
PolandStudy on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines
GermanyThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
